Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EXECUTIVE CHANGES: Johnson Service Group hires new CFO from Treatt

24th Mar 2025 10:45

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Johnson Service Group PLC - Cheshire-based textile services - Hires Ryan Govender to be its next chief financial officer, starting on October 1. Govender currently is CFO of Treatt PLC, which makes extracts and ingredients for the beverage, flavour and fragrance industries. Treatt says Govender will leave on September 30, having served three years in post. It has started the search for his successor. Prior to joining Treatt, Govender worked at Associated British Foods PLC. At Johnson Service Group, Govender replaces Yvonne Monaghan, who will retire after 40 years with the company and 17 as CFO.

----------

Argo Blockchain PLC - blockchain technology company focused on cryptocurrency mining with operations in the US and Canada - Hires Justin Nolan as chief executive officer, returning to Argo after having previously been its chief growth officer. In between, Nolan was CEO of Arkon Energy, a digital infrastructure company. Nolan had co-founded DPN LLS, which was acquired by Argo in 2021.

----------

Abingdon Health PLC - York, England-based developer, manufacturer and distributor of lateral flow disease tests - CEO Chris Yates moves to the new role of president of Abingdon Health USA Inc, leading the US business, plus commercial activities globally. Executive Chair Chris Hand will take over group CEO duties. Abingdon also hires Katie Brenner as an independent non-executive director. Based in Madison, Wisconsin, Brenner founded bluDiagnostics, which provides lateral flow testing and at-home monitoring of female fertility. Brenner sold bluDiagnostics to Amazon.com Inc in 2020 and remained there until last year.

----------

Celadon Pharmaceuticals PLC - London-based developer of cannabis-based medicines - Plans to call general meeting to propose cancellation of its shares from AIM, with a matched bargain facility provided to shareholders by JP Jenkins to trade shares. All four non-executive directors resign on Friday following the proposal by James Short, Celadon's CEO and 39.5% shareholder. The board now consists only of Short and Chair Alexander Anton. If the cancellation from AIM is approved, Anton also expects to resign. Celadon shares are down 39% to 8.58 pence on Monday morning in London. It has a market capitalisation of about GBP6 million.

----------

By Tom Waite, Alliance News editor

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

Johnson ServiceTreattAB FoodsArgo Blockchai.Abingdon Healt.Celadon Pharmaceuticals
FTSE 100 Latest
Value8,675.06
Change11.26